financetom
Business
financetom
/
Business
/
Newmont Continues to Expect $2 Billion From Divestiture Program, CFO Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newmont Continues to Expect $2 Billion From Divestiture Program, CFO Says
Sep 17, 2024 11:13 AM

01:58 PM EDT, 09/17/2024 (MT Newswires) -- Newmont ( NEM ) continues to expect proceeds of at least $2 billion from its divestiture program, which is on track to be completed by the end of Q1 of 2025, Chief Financial Officer Karyn Ovelmen said Tuesday, according to a Capital IQ transcript.

The divestiture of noncore assets will allow the gold miner to "really focus" on its core portfolio as well as reduce debt and buy back shares, Ovelmen said at a forum in Denver.

On Sept. 10, the company announced that it agreed to sell two Australian assets to Greatland Gold for gross proceeds of up to $475 million. The deal, expected to close in Q4, was the first asset sale in the divestiture program announced in February, the company said then.

At the Denver forum, Ovelmen said the process for the divestiture of six noncore assets and a project "is going very well."

Price: 52.92, Change: -0.21, Percent Change: -0.40

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Traders seek refuge in Aussie consumer staples as US tariffs spark market fall
Traders seek refuge in Aussie consumer staples as US tariffs spark market fall
Apr 3, 2025
By Rajasik Mukherjee (Reuters) - Shares of Australia's consumer staple companies rose on Thursday, driven by grocers Coles and Woolworths, as investors moved to safer bets after U.S. President Donald Trump's reciprocal tariffs sparked global market turmoil. Shares of the sector ended 1.3% higher while the broader Australian market fell 0.9% to its lowest since March 14. Coles rose 2.1%...
Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate
Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate
Apr 3, 2025
04:23 AM EDT, 04/03/2025 (MT Newswires) -- Mesoblast (MESO) said late Wednesday it expets to have a type B meeting with the US Food and Drug Administration during the current quarter to discuss the accelerated approval pathway for ischemic heart failure treatment candidate, Revascor. The main goals of the meeting are to get FDA feedback on relevant chemistry, manufacturing &...
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Apr 3, 2025
04:35 AM EDT, 04/03/2025 (MT Newswires) -- The slate of tariffs from the Trump administration is worse than the worst case scenario feared by analysts, according to Wedbush Securities. In a note emailed to clients on Wednesday, Wedbush analysts, led by Daniel Ives, said tech stocks will be under major pressure following the announcement. On Wednesday, the Trump administration unveiled...
Novartis Gets FDA Accelerated Approval for Vanrafia
Novartis Gets FDA Accelerated Approval for Vanrafia
Apr 3, 2025
04:41 AM EDT, 04/03/2025 (MT Newswires) -- Novartis ( NVS ) said late Wednesday the US Food and Drug Administration granted accelerated approval for Vanrafia to reduce proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapid disease progression. IgAN is a progressive, rare kidney disease. Data from an ongoing phase III showed that Vanrafia achieved...
Copyright 2023-2025 - www.financetom.com All Rights Reserved